AUY922 Completed Phase 1 / 2 Trials for Adenocarcinoma of the Lung / Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs